{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:25:26Z","timestamp":1789500326943,"version":"build-2803163510"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-022-08942-0","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T10:03:21Z","timestamp":1654077801000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autoimmunity in Primary Immunodeficiencies (PID)"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-3996","authenticated-orcid":false,"given":"Grace T.","family":"Padron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian P.","family":"Hernandez-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"5","key":"8942_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","volume":"140","author":"A Fischer","year":"2017","unstructured":"Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N (2017) Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol 140(5):1388-1393.e1388","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","volume":"6","author":"M Carneiro-Sampaio","year":"2015","unstructured":"Carneiro-Sampaio M, Coutinho A (2015) Early-onset autoimmune disease as a manifestation of primary immunodeficiency. Front Immunol 6:185","journal-title":"Front Immunol"},{"issue":"13","key":"8942_CR3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS et al (2014) Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 123(13):1989\u20131999","journal-title":"Blood"},{"issue":"1","key":"8942_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","volume":"134","author":"J Hadjadj","year":"2019","unstructured":"Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Mag\u00e9rus-Chatinet A, Mazerolles F, Stolzenberg MC, Jacques S, Picard C, Rosain J et al (2019) Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood 134(1):9\u201321","journal-title":"Blood"},{"issue":"15","key":"8942_CR5","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","volume":"124","author":"MG Seidel","year":"2014","unstructured":"Seidel MG (2014) Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood 124(15):2337\u20132344","journal-title":"Blood"},{"key":"8942_CR6","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","volume":"9","author":"E Gambineri","year":"2018","unstructured":"Gambineri E, Ciullini Mannurita S, Hagin D, Vignoli M, Anover-Sombke S, DeBoer S, Segundo GRS, Allenspach EJ, Favre C, Ochs HD et al (2018) Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Front Immunol 9:2411","journal-title":"Front Immunol"},{"issue":"5","key":"8942_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10875-015-0176-y","volume":"35","author":"K Kisand","year":"2015","unstructured":"Kisand K, Peterson P (2015) Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol 35(5):463\u2013478","journal-title":"J Clin Immunol"},{"issue":"5","key":"8942_CR8","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaci.2012.03.025","volume":"129","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C, Maglione PJ (2012) Common variable immunodeficiency. J Allergy Clin Immunol 129(5):1425-1426.e1423","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","volume":"7","author":"D Buchbinder","year":"2014","unstructured":"Buchbinder D, Nugent DJ, Fillipovich AH (2014) Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet 7:55\u201366","journal-title":"Appl Clin Genet"},{"key":"8942_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-1-4939-9424-3_34","volume":"1982","author":"EL Falcone","year":"2019","unstructured":"Falcone EL, Holland SM (2019) Gastrointestinal complications in chronic granulomatous disease. Methods Mol Biol 1982:573\u2013586","journal-title":"Methods Mol Biol"},{"key":"8942_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2020.00239","volume":"11","author":"AY Chan","year":"2020","unstructured":"Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M et al (2020) Hematopoietic cell transplantation in patients with primary immune regulatory disorders (PIRD): a Primary Immune Deficiency Treatment Consortium (PIDTC) survey. Front Immunol 11:239","journal-title":"Front Immunol"},{"issue":"4","key":"8942_CR12","first-page":"731","volume":"35","author":"M Saifi","year":"2015","unstructured":"Saifi M, Wysocki CA (2015) Autoimmune disease in primary immunodeficiency: at the crossroads of anti-infective immunity and self-tolerance. Immunol Allergy Clin 35(4):731\u2013752","journal-title":"Immunol Allergy Clin"},{"issue":"1","key":"8942_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","volume":"137","author":"B Grimbacher","year":"2016","unstructured":"Grimbacher B, Warnatz K, Yong PF, Korganow A-S, Peter H-H (2016) The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol 137(1):3\u201317","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fped.2016.00107","volume":"4","author":"G Giardino","year":"2016","unstructured":"Giardino G, Gallo V, Prencipe R, Gaudino G, Romano R, De Cataldis M, Lorello P, Palamaro L, Di Giacomo C, Capalbo D (2016) Unbalanced immune system: immunodeficiencies and autoimmunity. Front Pediatr 4:107","journal-title":"Front Pediatr"},{"key":"8942_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.molimm.2019.08.002","volume":"114","author":"J Schr\u00f6der-Braunstein","year":"2019","unstructured":"Schr\u00f6der-Braunstein J, Kirschfink M (2019) Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management. Mol Immunol 114:299\u2013311","journal-title":"Mol Immunol"},{"issue":"16","key":"8942_CR16","first-page":"3117","volume":"121","author":"HS Kuehn","year":"2013","unstructured":"Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DAL, Kuhns DB (2013) Loss-of-function of the protein kinase C \u03b4 (PKC\u03b4) causes a B-cell lymphoproliferative syndrome in humans. Blood TJ Am Soc Hematol 121(16):3117\u20133125","journal-title":"Blood TJ Am Soc Hematol"},{"issue":"20","key":"8942_CR17","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.3390\/jcm10204729","volume":"10","author":"G Costagliola","year":"2021","unstructured":"Costagliola G, Cappelli S, Consolini R (2021) Autoimmunity in primary immunodeficiency disorders: an updated review on pathogenic and clinical implications. J Clin Med 10(20):4729","journal-title":"J Clin Med"},{"issue":"1","key":"8942_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM et al (2020) Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol 40(1):66\u201381","journal-title":"J Clin Immunol"},{"issue":"4","key":"8942_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","volume":"133","author":"WT Shearer","year":"2014","unstructured":"Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O\u2019Reilly RJ, Fleisher TA et al (2014) Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 133(4):1092\u20131098","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8942_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2011.12.964","volume":"129","author":"RH Buckley","year":"2012","unstructured":"Buckley RH (2012) The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol 129(3):597\u2013604","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJM196508192730806","volume":"273","author":"GS Omenn","year":"1965","unstructured":"Omenn GS (1965) Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427\u2013432","journal-title":"N Engl J Med"},{"issue":"4","key":"8942_CR22","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/JCI115139","volume":"87","author":"G de Saint-Basile","year":"1991","unstructured":"de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N, Griscelli C, Fischer A (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn\u2019s syndrome). J Clin Invest 87(4):1352\u20131359","journal-title":"J Clin Invest"},{"issue":"2","key":"8942_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12026-015-8723-4","volume":"64","author":"X Bai","year":"2016","unstructured":"Bai X, Liu J, Zhang Z, Liu C, Zhang Y, Tang W, Dai R, Wu J, Tang X, Zhang Y et al (2016) Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome. Immunol Res 64(2):497\u2013507","journal-title":"Immunol Res"},{"issue":"11","key":"8942_CR24","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1182\/blood-2004-12-4861","volume":"105","author":"M Ege","year":"2005","unstructured":"Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, Schwarz K, Pannicke U (2005) Omenn syndrome due to ARTEMIS mutations. Blood 105(11):4179\u20134186","journal-title":"Blood"},{"issue":"5284","key":"8942_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.274.5284.97","volume":"274","author":"K Schwarz","year":"1996","unstructured":"Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S et al (1996) RAG mutations in human B cell-negative SCID. Science 274(5284):97\u201399","journal-title":"Science"},{"issue":"5","key":"8942_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0092-8674(00)81448-8","volume":"93","author":"A Villa","year":"1998","unstructured":"Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD et al (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93(5):885\u2013896","journal-title":"Cell"},{"issue":"2","key":"8942_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1172\/JCI332","volume":"102","author":"F Rieux-Laucat","year":"1998","unstructured":"Rieux-Laucat F, Bahadoran P, Brousse N, Selz F, Fischer A, Le Deist F, De Villartay JP (1998) Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn\u2019s syndrome. J Clin Invest 102(2):312\u2013321","journal-title":"J Clin Invest"},{"issue":"10","key":"8942_CR28","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1182\/blood.V94.10.3468.422k34_3468_3478","volume":"94","author":"S Signorini","year":"1999","unstructured":"Signorini S, Imberti L, Pirovano S, Villa A, Facchetti F, Ungari M, Bozzi F, Albertini A, Ugazio AG, Vezzoni P et al (1999) Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood 94(10):3468\u20133478","journal-title":"Blood"},{"issue":"1","key":"8942_CR29","first-page":"11","volume":"42","author":"F Le Deist","year":"1985","unstructured":"Le Deist F, Fischer A, Durandy A, Arnaud-Battandier F, Nezelof C, Hamet M, de Prost Y, Griscelli C (1985) Severe combined immune deficiency with hypereosinophilia: Immunologic study of 5 cases. Arch Fr Pediatr 42(1):11\u201316","journal-title":"Arch Fr Pediatr"},{"issue":"4","key":"8942_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/BF00792602","volume":"19","author":"F Facchetti","year":"1998","unstructured":"Facchetti F, Blanzuoli L, Ungari M, Alebardi O, Vermi W (1998) Lymph node pathology in primary combined immunodeficiency diseases. Springer Semin Immunopathol 19(4):459\u2013478","journal-title":"Springer Semin Immunopathol"},{"issue":"3","key":"8942_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1172\/JCI200523087","volume":"115","author":"P Cavadini","year":"2005","unstructured":"Cavadini P, Vermi W, Facchetti F, Fontana S, Nagafuchi S, Mazzolari E, Sediva A, Marrella V, Villa A, Fischer A et al (2005) AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 115(3):728\u2013732","journal-title":"J Clin Invest"},{"issue":"1","key":"8942_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jaci.2009.10.023","volume":"125","author":"B Cassani","year":"2010","unstructured":"Cassani B, Poliani PL, Moratto D, Sobacchi C, Marrella V, Imperatori L, Vairo D, Plebani A, Giliani S, Vezzoni P et al (2010) Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol 125(1):209\u2013216","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8942_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-3476(00)90061-1","volume":"136","author":"Y Kaino","year":"2000","unstructured":"Kaino Y, Otoh Y, Tokuda K, Hirai H, Ito T, Kida K (2000) Acquired hypothyroidism in a very young infant with Omenn\u2019s syndrome. J Pediatr 136(1):111\u2013113","journal-title":"J Pediatr"},{"issue":"3","key":"8942_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.20151116","volume":"213","author":"R Rigoni","year":"2016","unstructured":"Rigoni R, Fontana E, Guglielmetti S, Fosso B, D\u2019Erchia AM, Maina V, Taverniti V, Castiello MC, Mantero S, Pacchiana G et al (2016) Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects. J Exp Med 213(3):355\u2013375","journal-title":"J Exp Med"},{"issue":"7","key":"8942_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.humimm.2014.04.006","volume":"75","author":"CA Zago","year":"2014","unstructured":"Zago CA, Jacob CM, de Albuquerque Diniz EM, Lovisolo SM, Zerbini MC, Dorna M, Watanabe L, Fernandes JF, Rocha V, Oliveira JB et al (2014) Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias. Hum Immunol 75(7):662\u2013666","journal-title":"Hum Immunol"},{"issue":"6","key":"8942_CR36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I et al (2009) Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124(6):1289-1302.e1284","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"8942_CR37","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G et al (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361(21):2046\u20132055","journal-title":"N Engl J Med"},{"issue":"2","key":"8942_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, Kostyuchenko L, Genel F, K\u00fct\u00fckc\u00fcler N, Karaca N et al (2015) DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol 35(2):189\u2013198","journal-title":"J Clin Immunol"},{"issue":"2","key":"8942_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","volume":"136","author":"KR Engelhardt","year":"2015","unstructured":"Engelhardt KR, Gertz ME, Keles S, Sch\u00e4ffer AA, Sigmund EC, Glocker C, Saghafi S, Pourpak Z, Ceja R, Sassi A et al (2015) The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 136(2):402\u2013412","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12883-016-0578-3","volume":"16","author":"SA AlKhater","year":"2016","unstructured":"AlKhater SA (2016) CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report. BMC Neurol 16:54","journal-title":"BMC Neurol"},{"issue":"5","key":"8942_CR41","doi-asserted-by":"publisher","first-page":"e1458","DOI":"10.1542\/peds.2013-1383","volume":"134","author":"Z Jouhadi","year":"2014","unstructured":"Jouhadi Z, Khadir K, Ailal F, Bouayad K, Nadifi S, Engelhardt KR, Grimbacher B (2014) Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus. Pediatrics 134(5):e1458-1463","journal-title":"Pediatrics"},{"issue":"4","key":"8942_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","volume":"56","author":"A Etzioni","year":"2004","unstructured":"Etzioni A, Ochs HD (2004) The hyper IgM syndrome\u2013an evolving story. Pediatr Res 56(4):519\u2013525","journal-title":"Pediatr Res"},{"issue":"2","key":"8942_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12016-013-8378-7","volume":"46","author":"N Qamar","year":"2014","unstructured":"Qamar N, Fuleihan RL (2014) The hyper IgM syndromes. Clin Rev Allergy Immunol 46(2):120\u2013130","journal-title":"Clin Rev Allergy Immunol"},{"key":"8942_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","volume":"203","author":"V Lougaris","year":"2005","unstructured":"Lougaris V, Badolato R, Ferrari S, Plebani A (2005) Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 203:48\u201366","journal-title":"Immunol Rev"},{"issue":"Suppl 1","key":"8942_CR45","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1007\/s10875-008-9171-x","volume":"28","author":"AA Jesus","year":"2008","unstructured":"Jesus AA, Duarte AJ, Oliveira JB (2008) Autoimmunity in hyper-IgM syndrome. J Clin Immunol 28(Suppl 1):S62-66","journal-title":"J Clin Immunol"},{"key":"8942_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clim.2018.02.008","volume":"190","author":"V Lougaris","year":"2018","unstructured":"Lougaris V, Lanzi G, Baronio M, Gazzurelli L, Vairo D, Lorenzini T, Badolato R, Notarangelo LD, Boschi A, Moratto D et al (2018) Progressive severe B cell and NK cell deficiency with T cell senescence in adult CD40L deficiency. Clin Immunol 190:11\u201314","journal-title":"Clin Immunol"},{"issue":"6","key":"8942_CR47","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1046\/j.1365-2133.1998.02278.x","volume":"138","author":"KA Wolpert","year":"1998","unstructured":"Wolpert KA, Webster AD, Whittaker SJ (1998) Discoid lupus erythematosus associated with a primary immunodeficiency syndrome showing features of non-X-linked hyper-IgM syndrome. Br J Dermatol 138(6):1053\u20131057","journal-title":"Br J Dermatol"},{"issue":"4","key":"8942_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00002281-200307000-00009","volume":"15","author":"AV Gulino","year":"2003","unstructured":"Gulino AV, Notarangelo LD (2003) Hyper IgM syndromes. Curr Opin Rheumatol 15(4):422\u2013429","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"8942_CR49","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","volume":"36","author":"EA Leven","year":"2016","unstructured":"Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, Fuleihan RL, Geha RS, Cunningham CK, Bonilla FA, Conley ME et al (2016) Hyper IgM syndrome: a report from the USIDNET Registry. J Clin Immunol 36(5):490\u2013501","journal-title":"J Clin Immunol"},{"issue":"1","key":"8942_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaci.2017.06.036","volume":"141","author":"V Azzu","year":"2018","unstructured":"Azzu V, Kennard L, Morillo-Gutierrez B, Slatter M, Edgar JDM, Kumararatne DS, Griffiths WJH (2018) Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper-IgM but can be prevented by early hematopoietic stem cell transplantation. J Allergy Clin Immunol 141(1):405-408.e407","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8942_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N et al (2010) Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 125(2):424-432.e428","journal-title":"J Allergy Clin Immunol"},{"issue":"7157","key":"8942_CR52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O et al (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448(7157):1058\u20131062","journal-title":"Nature"},{"issue":"16","key":"8942_CR53","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML et al (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357(16):1608\u20131619","journal-title":"N Engl J Med"},{"issue":"8","key":"8942_CR54","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nri1885","volume":"6","author":"NC Reich","year":"2006","unstructured":"Reich NC, Liu L (2006) Tracking STAT nuclear traffic. Nat Rev Immunol 6(8):602\u2013612","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"8942_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0001-7310(14)70016-X","volume":"105","author":"Y Ling","year":"2014","unstructured":"Ling Y, Puel A (2014) IL-17 and infections. Actas Dermosifiliogr 105(Suppl 1):34\u201340","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"8942_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/rheumatology\/36.2.297","volume":"36","author":"J North","year":"1997","unstructured":"North J, Kotecha S, Houtman P, Whaley K (1997) Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol 36(2):297\u2013298","journal-title":"Br J Rheumatol"},{"issue":"7","key":"8942_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/rheumatology\/37.7.807b","volume":"37","author":"D Brugnoni","year":"1998","unstructured":"Brugnoni D, Franceschini F, Air\u00f2 P, Cattaneo R (1998) Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol 37(7):807\u2013808","journal-title":"Br J Rheumatol"},{"issue":"8","key":"8942_CR58","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s00467-006-0178-3","volume":"21","author":"M Yamazaki-Nakashimada","year":"2006","unstructured":"Yamazaki-Nakashimada M, Zaltzman-Girshevich S, Garcia de la Puente S, De Leon-Bojorge B, Espinosa-Padilla S, Saez-de-Ocariz M, Carrasco-Daza D, Hernandez-Bautista V, P\u00e9rez-Fernandez L, Espinosa-Rosales F (2006) Hyper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol 21(8):1200\u20131205","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"8942_CR59","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1007\/s10067-010-1439-x","volume":"32","author":"B Saikia","year":"2013","unstructured":"Saikia B, Aneja H, Jain J, Puliyel JM (2013) Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis. Clin Rheumatol 32(Suppl 1):S51-53","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8942_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1525-1470.2007.00577.x","volume":"25","author":"Z Erbagci","year":"2008","unstructured":"Erbagci Z (2008) Childhood bullous pemphigoid in association with hyperimmunoglobulin E syndrome. Pediatr Dermatol 25(1):28\u201333","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"8942_CR61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOH.0b013e32834114bc","volume":"18","author":"MH Albert","year":"2011","unstructured":"Albert MH, Notarangelo LD, Ochs HD (2011) Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol 18(1):42\u201348","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"8942_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0092-8674(94)90528-2","volume":"78","author":"JM Derry","year":"1994","unstructured":"Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78(4):635\u2013644","journal-title":"Cell"},{"issue":"23","key":"8942_CR63","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1182\/blood.2019002939","volume":"135","author":"LM Burroughs","year":"2020","unstructured":"Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S et al (2020) Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood 135(23):2094\u20132105","journal-title":"Blood"},{"issue":"2","key":"8942_CR64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaci.2020.06.018","volume":"146","author":"F Ferrua","year":"2020","unstructured":"Ferrua F, Marangoni F, Aiuti A, Roncarolo MG (2020) Gene therapy for Wiskott-Aldrich syndrome: history, new vectors, future directions. J Allergy Clin Immunol 146(2):262\u2013265","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fimmu.2012.00209","volume":"3","author":"M Catucci","year":"2012","unstructured":"Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A (2012) Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 3:209","journal-title":"Front Immunol"},{"issue":"1","key":"8942_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2214\/ajr.103.1.32","volume":"103","author":"JA Kirkpatrick Jr","year":"1968","unstructured":"Kirkpatrick JA Jr, DiGeorge AM (1968) Congenital absence of the thymus. Am J Roentgenol Radium Ther Nucl Med 103(1):32\u201337","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"6","key":"8942_CR67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0022-3476(79)80207-3","volume":"94","author":"ME Conley","year":"1979","unstructured":"Conley ME, Beckwith JB, Mancer JF, Tenckhoff L (1979) The spectrum of the DiGeorge syndrome. J Pediatr 94(6):883\u2013890","journal-title":"J Pediatr"},{"issue":"5","key":"8942_CR68","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, Keller M, Kobrynski LJ, Komarow HD, Mazer B et al (2015) Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 136(5):1186\u20131205","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"8942_CR69","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1242\/dev.087320","volume":"140","author":"AM Farley","year":"2013","unstructured":"Farley AM, Morris LX, Vroegindeweij E, Depreter ML, Vaidya H, Stenhouse FH, Tomlinson SR, Anderson RA, Cupedo T, Cornelissen JJ et al (2013) Dynamics of thymus organogenesis and colonization in early human development. Development 140(9):2015\u20132026","journal-title":"Development"},{"issue":"18","key":"8942_CR70","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1242\/dev.079400","volume":"139","author":"JR Gardiner","year":"2012","unstructured":"Gardiner JR, Jackson AL, Gordon J, Lickert H, Manley NR, Basson MA (2012) Localised inhibition of FGF signalling in the third pharyngeal pouch is required for normal thymus and parathyroid organogenesis. Development 139(18):3456\u20133466","journal-title":"Development"},{"key":"8942_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajmg.1320280508","volume":"3","author":"RA Thomas","year":"1987","unstructured":"Thomas RA, Landing BH, Wells TR (1987) Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl 3:43\u201366","journal-title":"Am J Med Genet Suppl"},{"issue":"1","key":"8942_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.diff.2012.04.005","volume":"84","author":"A Keyte","year":"2012","unstructured":"Keyte A, Hutson MR (2012) The neural crest in cardiac congenital anomalies. Differentiation 84(1):25\u201340","journal-title":"Differentiation"},{"issue":"12","key":"8942_CR73","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/jmg.34.12.986","volume":"34","author":"P de Lonlay-Debeney","year":"1997","unstructured":"de Lonlay-Debeney P, Cormier-Daire V, Amiel J, Abadie V, Odent S, Paupe A, Couderc S, Tellier AL, Bonnet D, Prieur M et al (1997) Features of DiGeorge syndrome and CHARGE association in five patients. J Med Genet 34(12):986\u2013989","journal-title":"J Med Genet"},{"issue":"4","key":"8942_CR74","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jpeds.2009.04.010","volume":"155","author":"AF Rope","year":"2009","unstructured":"Rope AF, Cragun DL, Saal HM, Hopkin RJ (2009) DiGeorge anomaly in the absence of chromosome 22q11.2 deletion. J Pediatr 155(4):560\u2013565","journal-title":"J Pediatr"},{"issue":"2","key":"8942_CR75","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clim.2010.02.007","volume":"135","author":"ML Markert","year":"2010","unstructured":"Markert ML, Devlin BH, McCarthy EA (2010) Thymus transplantation. Clin Immunol 135(2):236\u2013246","journal-title":"Clin Immunol"},{"issue":"4","key":"8942_CR76","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jaci.2004.01.766","volume":"113","author":"ML Markert","year":"2004","unstructured":"Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sempowski GD, Rhein ME, Szabolcs P, Hale LP et al (2004) Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 113(4):734\u2013741","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR77","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3389\/fimmu.2019.03099","volume":"10","author":"HX Wang","year":"2019","unstructured":"Wang HX, Pan W, Zheng L, Zhong XP, Tan L, Liang Z, He J, Feng P, Zhao Y, Qiu YR (2019) Thymic epithelial cells contribute to thymopoiesis and T cell development. Front Immunol 10:3099","journal-title":"Front Immunol"},{"issue":"6","key":"8942_CR78","doi-asserted-by":"publisher","first-page":"a006957","DOI":"10.1101\/cshperspect.a006957","volume":"4","author":"Y Xing","year":"2012","unstructured":"Xing Y, Hogquist KA (2012) T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 4(6):a006957","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"24","key":"8942_CR79","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1182\/blood.2018885244","volume":"133","author":"G Giardino","year":"2019","unstructured":"Giardino G, Radwan N, Koletsi P, Morrogh DM, Adams S, Ip W, Worth A, Jones A, Meyer-Parsonson I, Gaspar HB et al (2019) Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center. Blood 133(24):2586\u20132596","journal-title":"Blood"},{"issue":"5","key":"8942_CR80","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jaci.2011.06.043","volume":"128","author":"BE Tison","year":"2011","unstructured":"Tison BE, Nicholas SK, Abramson SL, Hanson IC, Paul ME, Seeborg FO, Shearer WT, Perez MD, Noroski LM, Chinen J (2011) Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome. J Allergy Clin Immunol 128(5):1115\u20131117","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8942_CR81","first-page":"294","volume":"63","author":"JH Choi","year":"2005","unstructured":"Choi JH, Shin YL, Kim GH, Seo EJ, Kim Y, Park IS, Yoo HW (2005) Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res 63(6):294\u2013299","journal-title":"Horm Res"},{"issue":"2","key":"8942_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/EJE-10-1206","volume":"165","author":"K Lima","year":"2011","unstructured":"Lima K, Abrahamsen TG, Wolff AB, Husebye E, Alimohammadi M, K\u00e4mpe O, F\u00f8lling I (2011) Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. Eur J Endocrinol 165(2):345\u2013352","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"8942_CR83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1067\/S0022-3476(03)00248-8","volume":"143","author":"S Lawrence","year":"2003","unstructured":"Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE (2003) Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr 143(2):277\u2013278","journal-title":"J Pediatr"},{"issue":"6","key":"8942_CR84","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC (1952) Agammaglobulinemia. Pediatrics 9(6):722\u2013728","journal-title":"Pediatrics"},{"key":"8942_CR85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","volume":"203","author":"ME Conley","year":"2005","unstructured":"Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA (2005) Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203:216\u2013234","journal-title":"Immunol Rev"},{"issue":"2","key":"8942_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1385\/CRIAI:19:2:183","volume":"19","author":"ME Conley","year":"2000","unstructured":"Conley ME, Rohrer J, Minegishi Y (2000) X-linked agammaglobulinemia. Clin Rev Allergy Immunol 19(2):183\u2013204","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"8942_CR87","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","volume":"75","author":"HD Ochs","year":"1996","unstructured":"Ochs HD, Smith CI (1996) X-linked agammaglobulinemia: A clinical and molecular analysis. Medicine (Baltimore) 75(6):287\u2013299","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"8942_CR88","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, Cazzola G, Consolini R, De Mattia D, Dell\u2019Erba G et al (2002) Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol 104(3):221\u2013230","journal-title":"Clin Immunol"},{"issue":"1","key":"8942_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood-2003-06-1964","volume":"103","author":"H Takada","year":"2004","unstructured":"Takada H, Kanegane H, Nomura A, Yamamoto K, Ihara K, Takahashi Y, Tsukada S, Miyawaki T, Hara T (2004) Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation. Blood 103(1):185\u2013187","journal-title":"Blood"},{"issue":"7","key":"8942_CR90","first-page":"2948","volume":"188","author":"D Vetrie","year":"1993","unstructured":"Vetrie D, Vo\u0159echovsk\u00fd I, Sideras P, Holland J, Davies A, Flinter F, Hammarstr\u00f6m L, Kinnon C, Levinsky R, Bobrow M et al (1993) (2012) The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. J Immunol 188(7):2948\u20132955","journal-title":"J Immunol"},{"issue":"2","key":"8942_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","volume":"72","author":"S Tsukada","year":"1993","unstructured":"Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S et al (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72(2):279\u2013290","journal-title":"Cell"},{"issue":"12","key":"8942_CR92","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/humu.20410","volume":"27","author":"J V\u00e4liaho","year":"2006","unstructured":"V\u00e4liaho J, Smith CI, Vihinen M (2006) BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat 27(12):1209\u20131217","journal-title":"Hum Mutat"},{"issue":"2","key":"8942_CR93","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/geno.1993.1066","volume":"15","author":"O Parolini","year":"1993","unstructured":"Parolini O, Hejtmancik JF, Allen RC, Belmont JW, Lassiter GL, Henry MJ, Barker DF, Conley ME (1993) Linkage analysis and physical mapping near the gene for X-linked agammaglobulinemia at Xq22. Genomics 15(2):342\u2013349","journal-title":"Genomics"},{"issue":"6","key":"8942_CR94","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","volume":"176","author":"NJ Horwood","year":"2006","unstructured":"Horwood NJ, Page TH, McDaid JP, Palmer CD, Campbell J, Mahon T, Brennan FM, Webster D, Foxwell BMJ (2006) Bruton\u2019s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 176(6):3635\u20133641","journal-title":"J Immunol"},{"issue":"2","key":"8942_CR95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clim.2007.10.005","volume":"126","author":"H Taneichi","year":"2008","unstructured":"Taneichi H, Kanegane H, Sira MM, Futatani T, Agematsu K, Sako M, Kaneko H, Kondo N, Kaisho T, Miyawaki T (2008) Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. Clin Immunol 126(2):148\u2013154","journal-title":"Clin Immunol"},{"issue":"28","key":"8942_CR96","doi-asserted-by":"publisher","first-page":"26258","DOI":"10.1074\/jbc.M301484200","volume":"278","author":"CA Jefferies","year":"2003","unstructured":"Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, Wietek C, Walch E, Wirth T, O\u2019Neill LA (2003) Bruton\u2019s tyrosine kinase is a Toll\/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem 278(28):26258\u201326264","journal-title":"J Biol Chem"},{"issue":"6","key":"8942_CR97","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/blood-2006-07-037960","volume":"109","author":"KR Sochorov\u00e1","year":"2006","unstructured":"Sochorov\u00e1 KR, Horv\u00e1th R, Ro\u017ekov\u00e1 D, Litzman J, Bartu\u030an\u030ckov\u00e1 J, \u0160ediv\u00e1 A, \u0160p\u00ed\u0161ek R (2006) Impaired Toll-like receptor 8\u2013mediated IL-6 and TNF-\u03b1 production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood 109(6):2553\u20132556","journal-title":"Blood"},{"issue":"6","key":"8942_CR98","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jaci.2013.12.1085","volume":"133","author":"V Lougaris","year":"2014","unstructured":"Lougaris V, Baronio M, Vitali M, Tampella G, Cattalini M, Tassone L, Soresina A, Badolato R, Plebani A (2014) Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. J Allergy Clin Immunol 133(6):1644-1650.e1644","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8942_CR99","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jcp.44.5.388","volume":"44","author":"C Kozlowski","year":"1991","unstructured":"Kozlowski C, Evans DI (1991) Neutropenia associated with X-linked agammaglobulinaemia. J Clin Pathol 44(5):388\u2013390","journal-title":"J Clin Pathol"},{"issue":"3","key":"8942_CR100","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/clin.1996.0188","volume":"81","author":"JE Farrar","year":"1996","unstructured":"Farrar JE, Rohrer J, Conley ME (1996) Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 81(3):271\u2013276","journal-title":"Clin Immunol Immunopathol"},{"issue":"4","key":"8942_CR101","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, Conley ME, Cunningham-Rundles C, Ochs HD (2006) X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine 85(4):193\u2013202","journal-title":"Medicine"},{"issue":"1","key":"8942_CR102","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1038\/ncomms8360","volume":"6","author":"M Ito","year":"2015","unstructured":"Ito M, Shichita T, Okada M, Komine R, Noguchi Y, Yoshimura A, Morita R (2015) Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun 6(1):7360","journal-title":"Nat Commun"},{"issue":"1","key":"8942_CR103","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2010.06.011","volume":"137","author":"TU Marron","year":"2010","unstructured":"Marron TU, Rohr K, Martinez-Gallo M, Yu J, Cunningham-Rundles C (2010) TLR signaling and effector functions are intact in XLA neutrophils. Clin Immunol 137(1):74\u201380","journal-title":"Clin Immunol"},{"issue":"4","key":"8942_CR104","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.4049\/jimmunol.1300125","volume":"192","author":"RH Bonami","year":"2014","unstructured":"Bonami RH, Sullivan AM, Case JB, Steinberg HE, Hoek KL, Khan WN, Kendall PL (2014) Bruton\u2019s tyrosine kinase promotes persistence of mature anti-insulin B cells. J Immunol 192(4):1459\u20131470","journal-title":"J Immunol"},{"issue":"8","key":"8942_CR105","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/art.39657","volume":"68","author":"LE Nyhoff","year":"2016","unstructured":"Nyhoff LE, Barron BL, Johnson EM, Bonami RH, Maseda D, Fensterheim BA, Han W, Blackwell TS, Crofford LJ, Kendall PL (2016) Bruton\u2019s tyrosine kinase deficiency inhibits autoimmune arthritis in mice but fails to block immune complex-mediated inflammatory arthritis. Arthritis Rheumatol 68(8):1856\u20131868","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8942_CR106","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","volume":"34","author":"VP Hernandez-Trujillo","year":"2014","unstructured":"Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, Yel L, Sullivan KE (2014) Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol 34(6):627\u2013632","journal-title":"J Clin Immunol"},{"issue":"3","key":"8942_CR107","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","volume":"37","author":"S Barmettler","year":"2017","unstructured":"Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, Ballas ZK, Bonilla FA, Ochs HD, Walter JE (2017) Gastrointestinal Manifestations in X-linked Agammaglobulinemia. J Clin Immunol 37(3):287\u2013294","journal-title":"J Clin Immunol"},{"key":"8942_CR108","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2016.02.010","volume":"165","author":"E Garc\u00eda-Garc\u00eda","year":"2016","unstructured":"Garc\u00eda-Garc\u00eda E, Staines-Boone AT, Vargas-Hern\u00e1ndez A, Gonz\u00e1lez-Serrano ME, Carrillo-Tapia E, Mogica-Mart\u00ednez D, Berr\u00f3n-Ru\u00edz L, Segura-Mendez NH, Espinosa-Rosales FJ, Yamazaki-Nakashimada MA et al (2016) Clinical and mutational features of X-linked agammaglobulinemia in Mexico. Clin Immunol 165:38\u201344","journal-title":"Clin Immunol"},{"issue":"4","key":"8942_CR109","first-page":"464","volume":"33","author":"P Machado","year":"2008","unstructured":"Machado P, Santos A, Faria E, Silva J, Malcata A, Chieira C (2008) Arthritis and X-linked agammaglobulinemia. Acta Reumatol Port 33(4):464\u2013467","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"8942_CR110","first-page":"103","volume":"113","author":"SM Mois\u0103","year":"2009","unstructured":"Mois\u0103 SM, Rugin\u0103 A, Moraru E, Go\u0163ia S, Burlea M (2009) X-linked Bruton congenital agammaglobulinemia: Case report. Rev Med Chir Soc Med Nat Lasi 113(1):103\u2013107","journal-title":"Rev Med Chir Soc Med Nat Lasi"},{"issue":"2","key":"8942_CR111","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/03009742.2014.995699","volume":"44","author":"T Patiroglu","year":"2015","unstructured":"Patiroglu T, Akar HH, Gunduz Z, Sisko S, Ng YY (2015) X-linked agammaglobulinemia in two siblings with a novel mutation in the BTK gene who presented with polyarticular juvenile idiopathic arthritis. Scand J Rheumatol 44(2):168\u2013170","journal-title":"Scand J Rheumatol"},{"key":"8942_CR112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clim.2017.08.005","volume":"183","author":"D Sharma","year":"2017","unstructured":"Sharma D, Gupta A, Goel S, Sharma M, Rawat A, Singh S (2017) Large BTK gene mutation in a child with X-linked agammaglobulinemia and polyarthritis. Clin Immunol 183:109\u2013111","journal-title":"Clin Immunol"},{"issue":"9","key":"8942_CR113","first-page":"579","volume":"13","author":"A V\u00e1ncsa","year":"2011","unstructured":"V\u00e1ncsa A, T\u00f3th B, Szekanecz Z (2011) BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis. Isr Med Assoc J 13(9):579\u2013580","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"8942_CR114","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10067-014-2537-y","volume":"34","author":"Z Zhu","year":"2015","unstructured":"Zhu Z, Kang Y, Lin Z, Huang Y, Lv H, Li Y (2015) X-linked agammaglobulinemia combined with juvenile idiopathic arthritis and invasive Klebsiella pneumoniae polyarticular septic arthritis. Clin Rheumatol 34(2):397\u2013401","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8942_CR115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM196901092800205","volume":"280","author":"JB Robbins","year":"1969","unstructured":"Robbins JB, Skinner RG, Pearson HA (1969) Autoimmune hemolytic anemia in a child with congenital x-linked hypogammaglobulinemia. N Engl J Med 280(2):75\u201379","journal-title":"N Engl J Med"},{"issue":"1","key":"8942_CR116","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10875-009-9357-x","volume":"30","author":"L Yel","year":"2010","unstructured":"Yel L (2010) Selective IgA deficiency. J Clin Immunol 30(1):10\u201316","journal-title":"J Clin Immunol"},{"issue":"11\u201312","key":"8942_CR117","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2119\/molmed.2011.00195","volume":"17","author":"N Wang","year":"2011","unstructured":"Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, Rantap\u00e4\u00e4-Dahlqvist S, Elvin K, Truedsson L, Andersson BA et al (2011) Selective IgA deficiency in autoimmune diseases. Mol Med 17(11\u201312):1383\u20131396","journal-title":"Mol Med"},{"key":"8942_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100025","volume":"2","author":"S Swain","year":"2019","unstructured":"Swain S, Selmi C, Gershwin ME, Teuber SS (2019) The clinical implications of selective IgA deficiency. J Transl Autoimmun 2:100025","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"8942_CR119","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10875-009-9336-2","volume":"30","author":"J Mohammadi","year":"2010","unstructured":"Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, Hammarstr\u00f6m L (2010) IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol 30(1):138\u2013143","journal-title":"J Clin Immunol"},{"issue":"9","key":"8942_CR120","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ng.644","volume":"42","author":"RC Ferreira","year":"2010","unstructured":"Ferreira RC, Pan-Hammarstr\u00f6m Q, Graham RR, Gateva V, Font\u00e1n G, Lee AT, Ortmann W, Urcelay E, Fern\u00e1ndez-Arquero M, N\u00fa\u00f1ez C et al (2010) Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet 42(9):777\u2013780","journal-title":"Nat Genet"},{"issue":"5","key":"8942_CR121","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1053\/j.gastro.2008.02.019","volume":"134","author":"Y Asahina","year":"2008","unstructured":"Asahina Y, Izumi N, Hirayama I, Tanaka T, Sato M, Yasui Y, Komatsu N, Umeda N, Hosokawa T, Ueda K et al (2008) Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 134(5):1396\u20131405","journal-title":"Gastroenterology"},{"issue":"1","key":"8942_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/gene.2008.83","volume":"10","author":"International Multiple Sclerosis Genetics Consortium","year":"2009","unstructured":"International Multiple Sclerosis Genetics Consortium (2009) The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 10(1):11\u201314","journal-title":"Genes Immun"},{"issue":"7","key":"8942_CR123","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ng2068","volume":"39","author":"JA Todd","year":"2007","unstructured":"Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39(7):857\u2013864","journal-title":"Nat Genet"},{"issue":"7153","key":"8942_CR124","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06010","volume":"448","author":"H Hakonarson","year":"2007","unstructured":"Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R, Casalunovo T, Taback SP, Frackelton EC et al (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448(7153):591\u2013594","journal-title":"Nature"},{"issue":"1","key":"8942_CR125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/gene.2008.84","volume":"10","author":"M Zoledziewska","year":"2009","unstructured":"Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, Moi L, Zavattari P, Murru R, Lampis R, Morelli L et al (2009) Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun 10(1):15\u201317","journal-title":"Genes Immun"},{"issue":"1","key":"8942_CR126","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1365-2265.2008.03437.x","volume":"71","author":"X Wu","year":"2009","unstructured":"Wu X, Zhu X, Wang X, Ma J, Zhu S, Li J, Liu Y (2009) Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin Endocrinol (Oxf) 71(1):46\u201349","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"8942_CR127","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/gene.2010.70","volume":"12","author":"MV Reddy","year":"2011","unstructured":"Reddy MV, Wang H, Liu S, Bode B, Reed JC, Steed RD, Anderson SW, Steed L, Hopkins D, She JX (2011) Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun 12(3):208\u2013212","journal-title":"Genes Immun"},{"issue":"1","key":"8942_CR128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/ard.2008.098376","volume":"69","author":"A Mart\u00ednez","year":"2010","unstructured":"Mart\u00ednez A, Perdigones N, C\u00e9nit MC, Espino L, Varad\u00e9 J, Lamas JR, Santiago JL, Fern\u00e1ndez-Arquero M, de la Calle H, Arroyo R et al (2010) Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 69(1):309\u2013311","journal-title":"Ann Rheum Dis"},{"issue":"3 Pt 1","key":"8942_CR129","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/clin.1996.0132","volume":"80","author":"T Espa\u00f1ol","year":"1996","unstructured":"Espa\u00f1ol T, Catala M, Hernandez M, Caragol I, Bertran JM (1996) Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 80(3 Pt 1):333\u2013335","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"8942_CR130","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000135694","volume":"147","author":"A Aghamohammadi","year":"2008","unstructured":"Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, Hammarstrom L (2008) Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 147(2):87\u201392","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"8942_CR131","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","volume":"145","author":"H Chapel","year":"2009","unstructured":"Chapel H, Cunningham-Rundles C (2009) Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145(6):709\u2013727","journal-title":"Br J Haematol"},{"key":"8942_CR132","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","volume":"11","author":"HE Ho","year":"2020","unstructured":"Ho HE, Cunningham-Rundles C (2020) Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol 11:149","journal-title":"Front Immunol"},{"issue":"5","key":"8942_CR133","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Dr\u00e4ger R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99(5):1544\u20131551","journal-title":"Blood"},{"issue":"5","key":"8942_CR134","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1586\/eci.09.43","volume":"5","author":"S Ahn","year":"2009","unstructured":"Ahn S, Cunningham-Rundles C (2009) Role of B cells in common variable immune deficiency. Expert Rev Clin Immunol 5(5):557\u2013564","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"8942_CR135","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarstr\u00f6m L, Nonoyama S, Quinti I et al (2016) International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4(1):38\u201359","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"8942_CR136","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng1600","volume":"37","author":"U Salzer","year":"2005","unstructured":"Salzer U, Chapel HM, Webster AD, Pan-Hammarstr\u00f6m Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Sch\u00e4ffer AA et al (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37(8):820\u2013828","journal-title":"Nat Genet"},{"issue":"8","key":"8942_CR137","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng1601","volume":"37","author":"E Castigli","year":"2005","unstructured":"Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37(8):829\u2013834","journal-title":"Nat Genet"},{"issue":"5","key":"8942_CR138","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","volume":"120","author":"L Zhang","year":"2007","unstructured":"Zhang L, Radigan L, Salzer U, Behrens TW, Grimbacher B, Diaz G, Bussel J, Cunningham-Rundles C (2007) Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 120(5):1178\u20131185","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"8942_CR139","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.4049\/jimmunol.1600017","volume":"196","author":"HM Jacobs","year":"2016","unstructured":"Jacobs HM, Thouvenel CD, Leach S, Arkatkar T, Metzler G, Scharping NE, Kolhatkar NS, Rawlings DJ, Jackson SW (2016) Cutting edge: BAFF promotes autoantibody production via TACI-dependent activation of transitional B cells. J Immunol 196(9):3525\u20133531","journal-title":"J Immunol"},{"issue":"5","key":"8942_CR140","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaci.2019.03.016","volume":"143","author":"O Scott","year":"2019","unstructured":"Scott O, Roifman CM (2019) NF-\u03baB pathway and the Goldilocks principle: lessons from human disorders of immunity and inflammation. J Allergy Clin Immunol 143(5):1688\u20131701","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8942_CR141","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","volume":"142","author":"P Tuijnenburg","year":"2018","unstructured":"Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, Stephens J, Carss KJ, Biasci D, Baxendale H et al (2018) Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol 142(4):1285\u20131296","journal-title":"J Allergy Clin Immunol"},{"key":"8942_CR142","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clim.2016.11.012","volume":"175","author":"V Lougaris","year":"2017","unstructured":"Lougaris V, Patrizi O, Baronio M, Tabellini G, Tampella G, Damiati E, Frede N, van der Meer JWM, Fliegauf M, Grimbacher B et al (2017) NFKB1 regulates human NK cell maturation and effector functions. Clin Immunol 175:99\u2013108","journal-title":"Clin Immunol"},{"key":"8942_CR143","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","volume":"10","author":"C Klemann","year":"2019","unstructured":"Klemann C, Camacho-Ordonez N, Yang L, Eskandarian Z, Rojas-Restrepo JL, Frede N, Bulashevska A, Heeg M, Al-Ddafari MS, Premm J et al (2019) Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Front Immunol 10:297","journal-title":"Front Immunol"},{"issue":"2","key":"8942_CR144","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Fieschi C, Thon V, Abedi MR, Hammarstrom L (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112(2):277\u2013286","journal-title":"Blood"},{"issue":"3","key":"8942_CR145","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","volume":"27","author":"I Quinti","year":"2007","unstructured":"Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, Franco D, Maria Pesce A, Borghese F et al (2007) Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27(3):308\u2013316","journal-title":"J Clin Immunol"},{"issue":"1","key":"8942_CR146","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR et al (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111(1):77\u201385","journal-title":"Blood"},{"key":"8942_CR147","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","volume":"8","author":"JR Farmer","year":"2017","unstructured":"Farmer JR, Ong MS, Barmettler S, Yonker LM, Fuleihan R, Sullivan KE, Cunningham-Rundles C, Walter JE (2017) Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets. Front Immunol 8:1740","journal-title":"Front Immunol"},{"issue":"1","key":"8942_CR148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","volume":"25","author":"J Wang","year":"2005","unstructured":"Wang J, Cunningham-Rundles C (2005) Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25(1):57\u201362","journal-title":"J Autoimmun"},{"issue":"11","key":"8942_CR149","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000467","volume":"7","author":"G Pollock","year":"2020","unstructured":"Pollock G, Sharma A, Gy M (2020) Autoimmune hepatitis in a patient with common variable immunodeficiency. ACG Case Rep J 7(11):e00467","journal-title":"ACG Case Rep J"},{"issue":"12","key":"8942_CR150","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106(12):R75-81","journal-title":"J Clin Invest"},{"issue":"1","key":"8942_CR151","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20\u201321","journal-title":"Nat Genet"},{"issue":"12","key":"8942_CR152","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jmg.38.12.874","volume":"38","author":"I Kobayashi","year":"2001","unstructured":"Kobayashi I, Shiari R, Yamada M, Kawamura N, Okano M, Yara A, Iguchi A, Ishikawa N, Ariga T, Sakiyama Y et al (2001) Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet 38(12):874\u2013876","journal-title":"J Med Genet"},{"issue":"2","key":"8942_CR153","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","volume":"119","author":"AA Caudy","year":"2007","unstructured":"Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW (2007) CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119(2):482\u2013487","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8942_CR154","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng1297-399","volume":"17","author":"J Aaltonen","year":"1997","unstructured":"Aaltonen J, Bj\u00f6rses P, Perheentupa J, Horelli-Kuitunen N, Palotie A, Peltonen L, Lee YS, Francis F, Henning S, Thiel C, Leharach H (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17(4):399\u2013403","journal-title":"Nat Genet"},{"issue":"1","key":"8942_CR155","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12714","volume":"287","author":"GM Constantine","year":"2019","unstructured":"Constantine GM, Lionakis MS (2019) Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev 287(1):103\u2013120","journal-title":"Immunol Rev"},{"issue":"12","key":"8942_CR156","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMra1713301","volume":"378","author":"ES Husebye","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O (2018) Autoimmune polyendocrine syndromes. N Engl J Med 378(12):1132\u20131141","journal-title":"N Engl J Med"},{"issue":"13","key":"8942_CR157","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88782","volume":"1","author":"EM Ferre","year":"2016","unstructured":"Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S et al (2016) Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight 1(13):e88782","journal-title":"JCI Insight"},{"key":"8942_CR158","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/353250","volume":"2012","author":"D Capalbo","year":"2012","unstructured":"Capalbo D, De Martino L, Giardino G, Di Mase R, Di Donato I, Parenti G, Vajro P, Pignata C, Salerno M (2012) Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol 2012:353250","journal-title":"Int J Endocrinol"},{"issue":"1","key":"8942_CR159","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar4141","volume":"15","author":"JR Garc\u00eda-Lozano","year":"2013","unstructured":"Garc\u00eda-Lozano JR, Torres-Agrela B, Montes-Cano MA, Ortiz-Fern\u00e1ndez L, Conde-Jald\u00f3n M, Teruel M, Garc\u00eda A, N\u00fa\u00f1ez-Rold\u00e1n A, Mart\u00edn J, Gonz\u00e1lez-Escribano MF (2013) Association of the AIRE gene with susceptibility to rheumatoid arthritis in a European population: a case control study. Arthritis Res Ther 15(1):R11","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8942_CR160","doi-asserted-by":"publisher","first-page":"14096","DOI":"10.1038\/s41598-017-14375-z","volume":"7","author":"B B\u00e9rczi","year":"2017","unstructured":"B\u00e9rczi B, Gerencs\u00e9r G, Farkas N, Hegyi P, Veres G, Bajor J, Czopf L, Alizadeh H, Rakonczay Z, Vigh \u00c9 et al (2017) Association between AIRE gene polymorphism and rheumatoid arthritis: a systematic review and meta-analysis of case-control studies. Sci Rep 7(1):14096","journal-title":"Sci Rep"},{"issue":"8","key":"8942_CR161","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.humimm.2016.06.002","volume":"77","author":"R Colobran","year":"2016","unstructured":"Colobran R, Gim\u00e9nez-Barcons M, Mar\u00edn-S\u00e1nchez A, Porta-Pardo E, Pujol-Borrell R (2016) AIRE genetic variants and predisposition to polygenic autoimmune disease: the case of Graves\u2019 disease and a systematic literature review. Hum Immunol 77(8):643\u2013651","journal-title":"Hum Immunol"},{"issue":"6","key":"8942_CR162","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81(6):935\u2013946","journal-title":"Cell"},{"issue":"4","key":"8942_CR163","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","volume":"125","author":"I Caminha","year":"2010","unstructured":"Caminha I, Fleisher TA, Hornung RL, Dale JK, Niemela JE, Price S, Davis J, Perkins K, Dowdell KC, Brown MR et al (2010) Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol 125(4):946-949.e946","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8942_CR164","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.clinbiochem.2012.01.016","volume":"45","author":"RA Bowen","year":"2012","unstructured":"Bowen RA, Dowdell KC, Dale JK, Drake SK, Fleisher TA, Hortin GL, Remaley AT, Nexo E, Rao VK (2012) Elevated vitamin B12 levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes. Clin Biochem 45(6):490\u2013492","journal-title":"Clin Biochem"},{"issue":"14","key":"8942_CR165","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT et al (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116(14):e35-40","journal-title":"Blood"},{"issue":"1","key":"8942_CR166","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, R\u00f6sen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J et al (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98(1):194\u2013200","journal-title":"Blood"},{"issue":"18","key":"8942_CR167","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, Lanzarotti N, Stolzenberg MC, Bader-Meunier B, Aladjidi N et al (2011) A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 118(18):4798\u20134807","journal-title":"Blood"},{"issue":"5","key":"8942_CR168","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00467-003-1087-3","volume":"18","author":"H Kanegane","year":"2003","unstructured":"Kanegane H, Vilela MM, Wang Y, Futatani T, Matsukura H, Miyawaki T (2003) Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis. Pediatr Nephrol 18(5):454\u2013456","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"8942_CR169","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"SE Flanagan","year":"2014","unstructured":"Flanagan SE, Haapaniemi E, Russell MA, Caswell R, Allen HL, De Franco E, McDonald TJ, Rajala H, Ramelius A, Barton J et al (2014) Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 46(8):812\u2013814","journal-title":"Nat Genet"},{"issue":"4","key":"8942_CR170","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi EM, Kaustio M, Rajala HL, van Adrichem AJ, Kainulainen L, Glumoff V, Doffinger R, Kuusanm\u00e4ki H, Heiskanen-Kosma T, Trotta L et al (2015) Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 125(4):639\u2013648","journal-title":"Blood"},{"issue":"4","key":"8942_CR171","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N et al (2015) Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125(4):591\u2013599","journal-title":"Blood"},{"issue":"6","key":"8942_CR172","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","volume":"90","author":"G Lopez-Herrera","year":"2012","unstructured":"Lopez-Herrera G, Tampella G, Pan-Hammarstr\u00f6m Q, Herholz P, Trujillo-Vargas CM, Phadwal K, Simon AK, Moutschen M, Etzioni A, Mory A et al (2012) Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 90(6):986\u20131001","journal-title":"Am J Hum Genet"},{"issue":"6","key":"8942_CR173","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jaci.2012.07.035","volume":"130","author":"SO Burns","year":"2012","unstructured":"Burns SO, Zenner HL, Plagnol V, Curtis J, Mok K, Eisenhut M, Kumararatne D, Doffinger R, Thrasher AJ, Nejentsev S (2012) LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J Allergy Clin Immunol 130(6):1428\u20131432","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"8942_CR174","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","volume":"7","author":"S Habibi","year":"2019","unstructured":"Habibi S, Zaki-Dizaji M, Rafiemanesh H, Lo B, Jamee M, G\u00e1mez-D\u00edaz L, Salami F, Kamali AN, Mohammadi H, Abolhassani H et al (2019) Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review. J Allergy Clin Immunol Pract 7(7):2379-2386.e2375","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"8942_CR175","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaci.2014.10.019","volume":"135","author":"LM Charbonnier","year":"2015","unstructured":"Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, Massaad MJ, Garcia-Lloret M, Hanna-Wakim R, Dbaibo G et al (2015) Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 135(1):217\u2013227","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8942_CR176","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jaci.2012.05.043","volume":"130","author":"A Alangari","year":"2012","unstructured":"Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, Raddaoui E, Almomen AK, Al-Muhsen S, Geha RS et al (2012) LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 130(2):481-488.e482","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8942_CR177","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1210\/jc.2015-3382","volume":"101","author":"F Schreiner","year":"2016","unstructured":"Schreiner F, Plamper M, Dueker G, Schoenberger S, G\u00e1mez-D\u00edaz L, Grimbacher B, Hilger AC, Gohlke B, Reutter H, Woelfle J (2016) Infancy-onset T1DM, Short stature, and severe immunodysregulation in two siblings with a homozygous LRBA mutation. J Clin Endocrinol Metab 101(3):898\u2013904","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"8942_CR178","first-page":"327","volume":"35","author":"SM Al-Mayouf","year":"2017","unstructured":"Al-Mayouf SM, Naji H, Alismail K, Alazami AM, Sheikh F, Conca W, Al-Mousa H (2017) Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis? Clin Exp Rheumatol 35(2):327\u2013329","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8942_CR179","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MIB.0000000000000266","volume":"21","author":"NK Serwas","year":"2015","unstructured":"Serwas NK, Kansu A, Santos-Valente E, Kulo\u011flu Z, Demir A, Yaman A, Gamez Diaz LY, Artan R, Sayar E, Ensari A et al (2015) Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis 21(1):40\u201347","journal-title":"Inflamm Bowel Dis"},{"issue":"100","key":"8942_CR180","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","volume":"45","author":"LS Walker","year":"2013","unstructured":"Walker LS (2013) Treg and CTLA-4: two intertwining pathways to immune tolerance. J Autoimmun 45(100):49\u201357","journal-title":"J Autoimmun"},{"issue":"6204","key":"8942_CR181","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, Schickel JN, Tran DQ, Stoddard J, Zhang Y et al (2014) Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345(6204):1623\u20131627","journal-title":"Science"},{"issue":"12","key":"8942_CR182","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1136\/gutjnl-2014-308541","volume":"64","author":"S Zeissig","year":"2015","unstructured":"Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S et al (2015) Early-onset Crohn\u2019s disease and autoimmunity associated with a variant in CTLA-4. Gut 64(12):1889\u20131897","journal-title":"Gut"},{"issue":"6","key":"8942_CR183","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P, Pati\u00f1o V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M et al (2018) Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol 142(6):1932\u20131946","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8942_CR184","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archpedi.1959.02070010389004","volume":"97","author":"RA Bridges","year":"1959","unstructured":"Bridges RA, Berendes H, Good RA (1959) A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 97(4):387\u2013408","journal-title":"AMA J Dis Child"},{"issue":"27","key":"8942_CR185","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363(27):2600\u20132610","journal-title":"N Engl J Med"},{"issue":"5","key":"8942_CR186","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s10875-012-9698-8","volume":"32","author":"C Martel","year":"2012","unstructured":"Martel C, Mollin M, Beaumel S, Brion JP, Coutton C, Satre V, Vieville G, Callanan M, Lefebvre C, Salmon A et al (2012) Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes. J Clin Immunol 32(5):942\u2013958","journal-title":"J Clin Immunol"},{"issue":"12","key":"8942_CR187","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/0009922810370057","volume":"49","author":"R Ameratunga","year":"2010","unstructured":"Ameratunga R, Woon ST, Vyas J, Roberts S (2010) Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergency. Clin Pediatr (Phila) 49(12):1143\u20131146","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"8942_CR188","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/myc.12049","volume":"56","author":"J Dotis","year":"2013","unstructured":"Dotis J, Pana ZD, Roilides E (2013) Non-Aspergillus fungal infections in chronic granulomatous disease. Mycoses 56(4):449\u2013462","journal-title":"Mycoses"},{"issue":"8","key":"8942_CR189","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/ni1096","volume":"5","author":"SH Jackson","year":"2004","unstructured":"Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5(8):818\u2013827","journal-title":"Nat Immunol"},{"issue":"7175","key":"8942_CR190","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature06471","volume":"451","author":"L Romani","year":"2008","unstructured":"Romani L, Fallarino F, De Luca A, Montagnoli C, D\u2019Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U et al (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451(7175):211\u2013215","journal-title":"Nature"},{"issue":"41","key":"8942_CR191","doi-asserted-by":"publisher","first-page":"17686","DOI":"10.1073\/pnas.1012016107","volume":"107","author":"MD Kraaij","year":"2010","unstructured":"Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C et al (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 107(41):17686\u201317691","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8942_CR192","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cei.13300","volume":"197","author":"A van de Geer","year":"2019","unstructured":"van de Geer A, Cuadrado E, Slot MC, van Bruggen R, Amsen D, Kuijpers TW (2019) Regulatory T cell features in chronic granulomatous disease. Clin Exp Immunol 197(2):222\u2013229","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"8942_CR193","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1542\/peds.2005-1349","volume":"117","author":"SS De Ravin","year":"2006","unstructured":"De Ravin SS, Naumann N, Robinson MR, Barron KS, Kleiner DE, Ulrick J, Friend J, Anderson VL, Darnell D, Kang EM et al (2006) Sarcoidosis in chronic granulomatous disease. Pediatrics 117(3):e590-595","journal-title":"Pediatrics"},{"issue":"5","key":"8942_CR194","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/art.1780370524","volume":"37","author":"BW Lee","year":"1994","unstructured":"Lee BW, Yap HK (1994) Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum 37(5):773\u2013776","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8942_CR195","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","volume":"122","author":"SS De Ravin","year":"2008","unstructured":"De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, Balow JE, Barron KS, Turner ML, Gallin JI et al (2008) Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 122(6):1097\u20131103","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8942_CR196","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","volume":"141","author":"BE Marciano","year":"2018","unstructured":"Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, Kreuzburg S, Yockey L, Hunsberger S, Foruraghi L et al (2018) X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. J Allergy Clin Immunol 141(1):365\u2013371","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"8942_CR197","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s10875-013-9939-5","volume":"33","author":"AC Battersby","year":"2013","unstructured":"Battersby AC, Cale AM, Goldblatt D, Gennery AR (2013) Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease. J Clin Immunol 33(8):1276\u20131284","journal-title":"J Clin Immunol"},{"issue":"9","key":"8942_CR198","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler J, Bengtsson AA, Blom AM (2014) The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis 73(9):1601\u20131606","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8942_CR199","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaci.2004.02.003","volume":"113","author":"L Wen","year":"2004","unstructured":"Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113(4):585\u2013593","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8942_CR200","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0961203309346508","volume":"19","author":"R Aggarwal","year":"2010","unstructured":"Aggarwal R, Sestak AL, D\u2019Souza A, Dillon SP, Namjou B, Scofield RH (2010) Complete complement deficiency in a large cohort of familial systemic lupus erythematosus. Lupus 19(1):52\u201357","journal-title":"Lupus"},{"issue":"5","key":"8942_CR201","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s004670050638","volume":"13","author":"CD West","year":"1999","unstructured":"West CD, McAdams AJ (1999) The alternative pathway C3 convertase and glomerular deposits. Pediatr Nephrol 13(5):448\u2013453","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"8942_CR202","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02786513","volume":"18","author":"Y Levy","year":"1998","unstructured":"Levy Y, George J, Yona E, Shoenfeld Y (1998) Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation: An autoimmune phenomenon. Immunol Res 18(1):55\u201360","journal-title":"Immunol Res"},{"issue":"1","key":"8942_CR203","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00005792-199501000-00003","volume":"74","author":"JJ Wisnieski","year":"1995","unstructured":"Wisnieski JJ, Baer AN, Christensen J, Cupps TR, Flagg DN, Jones JV, Katzenstein PL, McFadden ER, McMillen JJ, Pick MA et al (1995) Hypocomplementemic urticarial vasculitis syndrome: Clinical and serologic findings in 18 patients. Medicine (Baltimore) 74(1):24\u201341","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"8942_CR204","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/RHU.0b013e318156b9e3","volume":"13","author":"BE Gilliam","year":"2007","unstructured":"Gilliam BE, Wolff AE, Moore TL (2007) Partial C4 deficiency in juvenile idiopathic arthritis patients. J Clin Rheumatol 13(5):256\u2013260","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"8942_CR205","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1056\/NEJMoa022836","volume":"349","author":"K Stengaard-Pedersen","year":"2003","unstructured":"Stengaard-Pedersen K, Thiel S, Gadjeva M, M\u00f8ller-Kristensen M, S\u00f8rensen R, Jensen LT, Sj\u00f8holm AG, Fugger L, Jensenius JC (2003) Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 349(6):554\u2013560","journal-title":"N Engl J Med"},{"issue":"1","key":"8942_CR206","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10875-019-00714-4","volume":"40","author":"MI Garc\u00eda-Laorden","year":"2020","unstructured":"Garc\u00eda-Laorden MI, Hern\u00e1ndez-Brito E, Mu\u00f1oz-Almagro C, Pavlovic-Nesic S, R\u00faa-Figueroa I, Briones ML, Rajas O, Border\u00edas L, Payeras A, Lorente L et al (2020) Should MASP-2 deficiency be considered a primary immunodeficiency? Relevance of the Lectin Pathway. J Clin Immunol 40(1):203\u2013210","journal-title":"J Clin Immunol"},{"issue":"3","key":"8942_CR207","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jaip.2018.12.022","volume":"7","author":"J Heimall","year":"2019","unstructured":"Heimall J (2019) Now is the time to use molecular gene testing for the diagnosis of primary immune deficiencies. J Allergy Clin Immunol Pract 7(3):833\u2013838","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"8942_CR208","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119(7):1650\u20131657","journal-title":"Blood"},{"issue":"8","key":"8942_CR209","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/08880010490514778","volume":"21","author":"F Ozsoylu","year":"2004","unstructured":"Ozsoylu F (2004) Megadose methylprednisolone for the treatment of patients with Evans syndrome. Pediatr Hematol Oncol 21(8):739\u2013740","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"8942_CR210","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/jcm10020216","volume":"10","author":"A Voulgaridou","year":"2021","unstructured":"Voulgaridou A, Kalfa TA (2021) Autoimmune hemolytic anemia in the pediatric setting. J Clin Med 10(2):216","journal-title":"J Clin Med"},{"issue":"23","key":"8942_CR211","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3(23):3829\u20133866","journal-title":"Blood Adv"},{"issue":"6","key":"8942_CR212","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaip.2016.08.004","volume":"4","author":"JE Walter","year":"2016","unstructured":"Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA (2016) Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies. J Allergy Clin Immunol Pract 4(6):1089\u20131100","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"8942_CR213","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","volume":"7","author":"A Kiykim","year":"2019","unstructured":"Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, Dogruel D, Karaca NE, Cogurlu MT, Bilir OA et al (2019) Abatacept as a long-term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract 7(8):2790-2800.e2715","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-022-08942-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:13:07Z","timestamp":1688634787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-022-08942-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":213,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["8942"],"URL":"https:\/\/doi.org\/10.1007\/s12016-022-08942-0","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"4 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"VHT reports conflict with Ad board for Takeda and CSL; Speaker for Takeda; Consultant for Takeda.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}